Review




Structured Review

CYBERNET SYSTEMS CO LTD endoscopic imaging support program endobrain-eye
AI‐SaMD approved as a medical device in the field of oncology in Japan (as of May 2024).
Endoscopic Imaging Support Program Endobrain Eye, supplied by CYBERNET SYSTEMS CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endoscopic+imaging+support+program+endobrain-eye/pmc11786316-2-3-9?v=CYBERNET+SYSTEMS+CO+LTD
Average 90 stars, based on 1 article reviews
endoscopic imaging support program endobrain-eye - by Bioz Stars, 2026-07
90/100 stars

Images

1) Product Images from "Current status and future direction of cancer research using artificial intelligence for clinical application"

Article Title: Current status and future direction of cancer research using artificial intelligence for clinical application

Journal: Cancer Science

doi: 10.1111/cas.16395

AI‐SaMD approved as a medical device in the field of oncology in Japan (as of May 2024).
Figure Legend Snippet: AI‐SaMD approved as a medical device in the field of oncology in Japan (as of May 2024).

Techniques Used: Diagnostic Assay, Imaging, Software, Computed Tomography, Biomarker Discovery



Similar Products

90
CYBERNET SYSTEMS CO LTD endoscopic imaging support program endobrain-eye
AI‐SaMD approved as a medical device in the field of oncology in Japan (as of May 2024).
Endoscopic Imaging Support Program Endobrain Eye, supplied by CYBERNET SYSTEMS CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endoscopic+imaging+support+program+endobrain-eye/pmc11786316-2-3-9?v=CYBERNET+SYSTEMS+CO+LTD
Average 90 stars, based on 1 article reviews
endoscopic imaging support program endobrain-eye - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


AI‐SaMD approved as a medical device in the field of oncology in Japan (as of May 2024).

Journal: Cancer Science

Article Title: Current status and future direction of cancer research using artificial intelligence for clinical application

doi: 10.1111/cas.16395

Figure Lengend Snippet: AI‐SaMD approved as a medical device in the field of oncology in Japan (as of May 2024).

Article Snippet: , 30200BZX00208000 , Endoscopic Imaging Support Program EndoBRAIN‐EYE , Cybernet Systems, Inc. , Colonoscopy , II , 2020.

Techniques: Diagnostic Assay, Imaging, Software, Computed Tomography, Biomarker Discovery